
Asymchem Biologics
凯莱英生物
Asymchem Biologics
Biotech/Healthcare
AsymBio is a subsidiary of Asymchem Pharmaceutical Group focused on CDMO services. It provides dedicated contract development and manufacturing services for large-molecule biologics, antibody-drug conjugates, cell and gene therapies, mRNA therapeutics, and other products.
Latest round: Strategic (2022)
Source: ChinaBulls — chinabulls.com
Last updated 2022-03-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.